Question 1

What are the most cited papers from Nuvo Pharmaceuticals (Canada)?

Accepted Answer

The most cited paper from Nuvo Pharmaceuticals (Canada) is "Efficacy and safety of topical diclofenac containing dimethyl sulfoxide (DMSO) compared with those of topical placebo, DMSO vehicle and oral diclofenac for knee osteoarthritis" (Lee S. Simon, Lisa M. Grierson, Zahid Naseer et al., 2009), with 197 citations. Next come "Effect of a topical diclofenac solution for relieving symptoms of primary osteoarthritis of the knee: a randomized controlled trial" (190) and "Treatment of osteoarthritis of the knee with a topical diclofenac solution: a randomised controlled, 6-week trial [ISRCTN53366886]" (104).

Question 2

Which research topics does Nuvo Pharmaceuticals (Canada) publish most on?

Accepted Answer

By volume in 2022-now: Information Retrieval and Search Behavior, Data Visualization and Analytics, Scientific Computing and Data Management and Topic Modeling.

Question 3

Which fields of science does Nuvo Pharmaceuticals (Canada) work in?

Accepted Answer

In all years, 50% of research at Nuvo Pharmaceuticals (Canada) is in Health Sciences, 23% in Life Sciences. Its largest fields are Medicine (50%), Computer Science (13%), Neuroscience (10%). It does 1.6× the world's share of Health Sciences.

Question 4

Is Nuvo Pharmaceuticals (Canada)'s research output growing?

Accepted Answer

Output in 2022-2025 was 294% higher than in 2018-2021.